HuGE Literature Finder
Records
1
-
21
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update. Clinical pharmacology and therapeutics 2020 Aug . Karnes Jason H, Rettie Allan E, Somogyi Andrew A, Huddart Rachel, Fohner Alison E, Formea Christine M, Lee Ming Ta Michael, Llerena Adrian, Whirl-Carrillo Michelle, Klein Teri E, Phillips Elizabeth J, Mintzer Scott, Gaedigk Andrea, Caudle Kelly E, Callaghan John |
| Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes. Clinical pharmacology and therapeutics 2020 May . Sukasem Chonlaphat, Pratoomwun Jirawat, Satapornpong Patompong, Klaewsongkram Jettanong, Rerkpattanapipat Ticha, Rerknimitr Pawinee, Lertpichitkul Pattamon, Puangpetch Apichaya, Nakkam Nontaya, Konyoung Parinya, Khunarkornsiri Usanee, Disphanurat Wareeporn, Srisuttiyakorn Chutika, Pattanacheewapull Oranuch, Kanjanawart Sirimas, Kongpan Thachanan, Chumworathayi Pansu, Saksit Niwat, Bruminhent Jackrapong, Tassaneeyakul Wichittra, Chantratita Wasun, Pirmohamed Munir, |
| Association of CYP2C9*3 with phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis. Journal of clinical pharmacy and therapeutics 2018 Jun 43 (3): 408-413. Wu X, Liu W, Zhou |
| The role of pharmacogenetics of cytochrome P450s in phenytoin-induced DRESS syndrome. Central-European journal of immunology 2018 43 (2): 220-221. Ya?ar Üm |
| Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions. European journal of clinical pharmacology 2017 Apr . Yampayon Kittika, Sukasem Chonlaphat, Limwongse Chanin, Chinvarun Yotin, Tempark Therdpong, Rerkpattanapipat Ticha, Kijsanayotin Pornpim |
| Genotyping of six clopidogrel-metabolizing enzyme polymorphisms has a minor role in the assessment of platelet reactivity in patients with acute coronary syndrome. Anatolian journal of cardiology 2017 Feb . García-Lagunar María Henar, Consuegra-Sánchez Luciano, Conesa-Zamora Pablo, Ruiz-Cosano Javier, Soria-Arcos Federico, García de Guadiana Luis, Vivar Pedro Cano, Castillo-Moreno Juan Antonio, Melgarejo-Moreno Anton |
| A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic Information. PloS one 2017 12 (1): e0169214. Silva-Alves Mariana S, Secolin Rodrigo, Carvalho Benilton S, Yasuda Clarissa L, Bilevicius Elizabeth, Alvim Marina K M, Santos Renato O, Maurer-Morelli Claudia V, Cendes Fernando, Lopes-Cendes Isc |
| Angiotensin-Converting Enzyme Inhibitors' Influence on Antiplatelet Therapy of Clopidogrel in ACS. Clinical laboratory 2016 Oct 62 (10): 1911-1918. Yang Shuo, Cui Chanjuan, Zhang Jie, Qiao R |
| Pharmacogenetic approach to losartan in Marfan patients: a starting point to improve dosing regimen? Drug metabolism and personalized therapy 2016 Jul . Falvella Felicia Stefania, Marelli Susan, Cheli Stefania, Montanelli Stefano, Viecca Federico, Salvi Lucia, Ferrara Alfio, Clementi Emilio, Trifirò Giuliana, Pini Alessand |
| Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population. Pharmacogenetics and genomics 2016 May 26 (5): 225-34. Tassaneeyakul Wichittra, Prabmeechai Napat, Sukasem Chonlaphat, Kongpan Thachanan, Konyoung Parinya, Chumworathayi Pansu, Tiamkao Somsak, Khunarkornsiri Usanee, Kulkantrakorn Kongkiat, Saksit Niwat, Nakkam Nontaya, Satapornpong Patompong, Vannaprasaht Suda, Sangviroon Alisara, Mahasirimongkol Surakameth, Wichukchinda Nuanjun, Rerkpattanapipat Ticha, Tassaneeyakul Wongwiw |
| Impact of CYP2C9 and VKORC1 genetic polymorphisms upon warfarin dose requirements in Egyptian patients with acute coronary syndrome. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2015 Jul 26 (5): 499-504. Ghozlan Manal F, Foad Dina A, Darwish Yasser W, Saad Abeer |
| [Predictive genomic markers for severe adverse drug reactions]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2015 135 (4): 589-95. Saito Yoshiro, Kodama Susumu, Sugiyama Emiko, Nakamura Ryosu |
| Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. JAMA 2014 Aug 312 (5): 525-34. Chung Wen-Hung, Chang Wan-Chun, Lee Yun-Shien, Wu Ying-Ying, Yang Chih-Hsun, Ho Hsin-Chun, Chen Ming-Jing, Lin Jing-Yi, Hui Rosaline Chung-Yee, Ho Ji-Chen, Wu Wei-Ming, Chen Ting-Jui, Wu Tony, Wu Yih-Ru, Hsih Mo-Song, Tu Po-Hsun, Chang Chen-Nen, Hsu Chien-Ning, Wu Tsu-Lan, Choon Siew-Eng, Hsu Chao-Kai, Chen Der-Yuan, Liu Chin-San, Lin Ching-Yuang, Kaniwa Nahoko, Saito Yoshiro, Takahashi Yukitoshi, Nakamura Ryosuke, Azukizawa Hiroaki, Shi Yongyong, Wang Tzu-Hao, Chuang Shiow-Shuh, Tsai Shih-Feng, Chang Chee-Jen, Chang Yu-Sun, Hung Shuen-Iu, , |
| Xenobiotic sensor- and metabolism-related gene variants in environmental sensitivity-related illnesses: a survey on the Italian population. Oxidative medicine and cellular longevity 2013 2013 831969. Caccamo Daniela, Cesareo Eleonora, Mariani Serena, Raskovic Desanka, Ientile Riccardo, Currò Monica, Korkina Liudmila, De Luca Chia |
| Genetic and clinical determinants influencing warfarin dosing in children with heart disease. Pediatric cardiology 2012 Nov . Nguyen N, Anley P, Yu MY, Zhang G, Thompson AA, Jennings LJ |
| Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patients. Biomarkers in medicine 2011 Aug 5 (4): 439-49. Ruaño Gualberto, Villagra David, Szarek Bonnie, Windemuth Andreas, Kocherla Mohan, Gorowski Krystyna, Berrezueta Christopher, Schwartz Harold I, Goethe Jo |
| Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndrome. Thrombosis research 2011 Jun 127 (6): 595-9. Ames Paul R J, Margaglione Maurizio, Ciampa Antonio, Colaizzo Donatella, Ferrara Felicetto, Iannaccone Luigi, Vincenzobrancacci |
| Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes. Toxicology and applied pharmacology 2010 Nov 248 (3): 285-92. De Luca Chiara, Scordo Maria G, Cesareo Eleonora, Pastore Saveria, Mariani Serena, Maiani Gianluca, Stancato Andrea, Loreti Beatrice, Valacchi Giuseppe, Lubrano Carla, Raskovic Desanka, De Padova Luigia, Genovesi Giuseppe, Korkina Liudmila |
| [Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin]. Terapevticheski? arkhiv 2010 82 (5): 33-9. Kondrat'eva L V, Patrusheva N L, Patrushev L I, Aleksandrova E N, Kovalenko T F, Ostriakova E V, Reshetniak T |
| Frequency of CYP3A4, CYP3A5, CYP2C9, and CYP2C19 variant alleles in patients receiving clopidogrel that experience repeat acute coronary syndrome. Heart and vessels 2009 Mar 24 (2): 73-8. Brackbill Marcia L, Kidd Robert S, Abdoo April D, Warner James G, Harralson Arthur |
| Is pharmacogenomics our future? Metformin, ovulation and polymorphism of the STK11 gene in polycystic ovary syndrome. Pharmacogenomics 2008 Aug 9 (8): 1163-5. Goldenberg Naila, Glueck Charles |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: